Cargando…
Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems
BACKGROUND: Recombinant Modified Vaccinia Virus Ankara has been employed as a safe and potent viral vector vaccine against infectious diseases and cancer. We generated recMVAs encoding norovirus GII.4 genotype capsid protein by using a marker-based approach and a BAC-based system. In the marker-base...
Autores principales: | Kugler, Franziska, Drexler, Ingo, Protzer, Ulrike, Hoffmann, Dieter, Moeini, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688233/ https://www.ncbi.nlm.nih.gov/pubmed/31399106 http://dx.doi.org/10.1186/s12985-019-1212-y |
Ejemplares similares
-
Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies
por: Moeini, Hassan, et al.
Publicado: (2021) -
Selection of recombinant MVA by rescue of the essential D4R gene
por: Ricci, Patricia S, et al.
Publicado: (2011) -
Bacterial artificial chromosomes improve recombinant protein production in mammalian cells
por: Blaas, Leander, et al.
Publicado: (2009) -
Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2008) -
Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2011)